Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on May 27, 2026, covering events occurring on May 26, 2026. The filing addresses the company's status regarding its listing on The Nasdaq Stock Market following a period of non-compliance with the minimum bid price requirement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance results.
Material Changes and Listing Status
- Regained Compliance: On May 26, 2026, Nasdaq formally notified the Company that it had regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule").
- Previous Status: The Company had previously received extensions to demonstrate compliance, with the final deadline set for May 18, 2026.
- Panel Jurisdiction: The Nasdaq Hearings Panel will maintain jurisdiction over the Company's listing until September 1, 2026.
Outlook, Risks, and Contingencies
- Mandatory Monitoring: The Company is subject to a Mandatory Panel Monitor for one year from May 26, 2026, through May 26, 2027.
- Delisting Risk: If the Company fails to maintain a closing bid price of at least $1.00 per share for 30 consecutive business days during the monitoring period, it will not be afforded the standard 180-day grace period. Instead, Nasdaq would issue a delisting determination immediately.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to various risk factors detailed in the Company's 2025 Form 10-K.
Key Facts for Investor Verification
- Verify the current trading price of JAGX to ensure it remains above the $1.00 threshold to avoid immediate delisting risk.
- Monitor the Company's stock price stability over the next 30 consecutive business days.
- Review the attached Press Release (Exhibit 99.1) for additional details on the Nasdaq Hearings Panel Decision Letter.
- Check future filings for any updates regarding the Mandatory Panel Monitor status before the September 1, 2026, jurisdiction expiration.